Sign in
Taking people in United StatesNo phase

Following people with thyroid disorders such as hyperthyroidism and hypothyroidism over time

Follows people with thyroid disorders to learn how they develop.

Key facts

Who runs it
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Where
Bethesda, United StatesSee the site
Trial code
Registry title
Natural History of Thyroid Function Disorders
Status
Recruiting
People taking part
2,500 people, planned
Started
1 Feb 1977
Type of study
Observational
Record updated
12 November 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with a known or suspected thyroid function disorder, or with abnormal thyroid blood tests. It studies how these conditions develop, show up and are inherited.

Age
6 Months to 98 Years
Sex
All sexes can join.
Disease stage
Known or suspected thyroid problems, such as an overactive thyroid (hyperthyroidism, including Graves' disease), an underactive thyroid (hypothyroidism), thyroid hormone resistance, or TSH-secreting pituitary tumors. People with abnormal thyroid function tests from other causes can also join.
Biomarker or test result
Abnormal thyroid function tests, or inherited changes in genes such as TSH-beta subunit, Pax-8, TTF-2, Pit-I, Tg, PDS and NIS, can be part of joining.

Main reasons for not taking part

  • People not willing to follow all study procedures or not available for the whole study cannot join.

The registry criteria, word for word

Show all 19 criteriaShow less

Who cannot take part

  • There are no exclusion criteria for subjects with known or suspected thyroid abnormalities

Other criteria

  • INCLUSION CRITERIA:; The categories of subjects eligible to participate in this study include:
  • Participants with known or suspected thyroid abnormalities (e.g. hypothyroidism, hyperthyroidism, extreme iodine deficiency, and inherited forms of hypothyroidism resulting from abnormalities in the expression of genes coding for the TSH- beta subunit, Pax-8, TTF-2, Pit-I, Tg, PDS, and NIS)
  • Participants with thyroid function test (TFT) abnormalities due to:; Non-thyroidal illness; Abnormalities of serum TH binding proteins leading to euthyroid hyperthyroxinemia or hypotriiodothyronemia; Genetic deficiency of thyroxine-binding globulin (TBG); Antibodies to mouse immunoglobulins leading to an artifactual elevation in the TSH ultrasensitive ("3rd generation") assay which may mimic "inappropriate" secretion of TSH; Inclusion and exclusion criteria for each group of subjects are given below; Participants with known or suspected thyroid abnormalities will be eligible to participate if the individual meets all of the following criteria:
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Male or female, aged 6 months+; Hyperthyroid states include but are not restricted to:
  • Graves' disease (GD) thought to result from thyroid-stimulating immunoglobulins (TSIg's), a subclass of which also stimulate eye muscle and fatty tissue producing exophthalmos (Graves' ophthalmopathy), as well as the skin in the pretibial area causing pretibial myxedema (Graves' dermopathy)
  • Subacute thyroiditis (SAT), a painful inflammation thought to result from viral infection with Coxsackie, as well as other viruses
  • Silent thyroiditis, a painless inflammation thought to result from autoimmune attack of thyrocytes by antimicrosomal antibodies directed against thyroid peroxidase (TPO), as well as antithyroglobulin(anti-Tg) antibodies
  • Single or multiple hyperfunctioning thyroid nodules of unknown etiology, probably resulting from the activation of certain thyroid oncogenes and/or growth factors, such as the thyrotropin (TSH) receptor (TSHR) and the a-subunit of the Gs protein (Gsa)
  • Iodide-induced hyperthyroidism of unknown etiology
  • Surreptitious administration of thyroid hormone (TH), usually present in participants with underlying psychiatric disease or occasionally related to participants with obesity and other eating disorders
  • Trophoblastic neoplasms, thought to result from high levels of hCG secretion, which, because of its structural similarity to TSH, causes "spillover" of action at the TSHR level
  • "Inappropriate" secretion of TSH, which may be present either in participants with TSH- producing pituitary tumors (TSHomas) or from a non-neoplastic cause, i.e. pituitary resistance to the action of thyroid hormone (3,4); The above are the principal variants of hyperthyroidism that we will study, although we may discover that certain participants may turn out to have rare causes of hyperthyroidism, e.g. unusual variants of ectopic thyroid tissue, "hyperfunctioning" thyroid cancer, choriocarcinoma, or ovarian teratomas. Finally, some participants may present with extreme thyrotoxic symptoms in the context of "thyroid storm" or, conversely, with apathetic thyrotoxicosis; Hypothyroid states include but are not restricted to:
  • Primary (or thyroidal) hypothyroidism, usually resulting from auto-antibodies to thyroid proteins, such as antimicrosomal antibodies to TPO usually associated with lymphocytic (Hashimoto's) thyroiditis (HT) or atrophic thyroiditis, or blocking antibodies to the TSHR, usually in the context of non-goitrous hypothyroidism
  • Secondary (or pituitary) hypothyroidism, usually resulting from tumors of the pituitary of non-thyrotropic origin such, as growth hormone (GH)-secreting tumors or prolactinomas
  • Tertiary (or hypothalamic) hypothyroidism, usually resulting from a deficiency in the hypothalamic hormone thyrotropin-releasing hormone (TRH), either of unknown etiology or secondary to a pituitary tumor
  • Bio-inactive TSH, either relating to an endogenous abnormality of hypothalamic hormones or secondary to pituitary tumors (and usually related to abnormal glycosylation patterns of the TSH molecule)
  • Generalized resistance to thyroid hormone (RTH), a disease which has been shown to be due to abnormalities in the TH receptor, c-erbA-beta (or TR- beta); The above are the principal disorders under study, but we may also investigate other abnormalities, such as extreme iodine deficiency, and inherited forms of hypothyroidism resulting from abnormalities in the expression of genes coding for the TSH- beta subunit, Pax-8, TTF-2, Pit-I, Tg, PDS, and NIS (among others)

Where in United States

  • National Institutes of Health Clinical CenterBethesda, United StatesContact: Padmasree Veeraraghavan, R.N.Taking people

About the trial

What the trial wants to find out

Participants in this study will be patients diagnosed with or suspected to have a thyroid function disorder. These conditions may include: hypothyroidism, hyperthyroidism, thyroid hormone resistance, Graves' Dermopathy, and thyroid-stimulating hormone (TSH) secreting pituitary adenomas.

Read full original descriptionShow less

The main purpose of this study is to further understand the natural history, clinical presentation, and genetics of thyroid function disorders. Many of the tests performed are in the context of standard medical care that is offered to all patients with thyroid function disorders. In addition, blood and tissue samples may be taken for research and genetic studies.

The group in the trial

  • Thyroid disorders

    Participants with thyroid disorders

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Natural History of Thyroid Function Disorders
Plain-language title
Following people with thyroid disorders such as hyperthyroidism and hypothyroidism over timeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
12 November 2026